Gemunu Hewawitharana
Research Subjects
Gemunu Hewawitharana has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Imalke Kankananarachchi
University of Ruhuna
6 shared publications - Eresha Jasinge
Department of Chemical Pathology, Lady Ridgeway Hospital for Children, Colombo, Sri Lanka
2 shared publications - John P. Phillips
University of New Mexico USA
2 shared publications - Sujeewa Amarasena
University of Ruhuna
2 shared publications - Ananda Kodithuwakku
District General Hospital Matara
1 shared publication Asha Madhushani Ui
Paediatric Neurology Unit Teaching Hospital Galle Sri Lanka
1 shared publication
Latest Publications
- Open Access
- 28 December 2024
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 67 (7) , 892-900
Prediction of cerebral palsy and cognitive delay among high‐risk children in a developing nation: A successful early detection programme
Aim: To determine the feasibility of combining the Hammersmith Infant Neurological Examination (HINE) and General Movements Assessment (GMA) within a standard follow‐up schedule to predict developmental outcomes in infants at risk in low‐ and middle‐income countries (LMICs).Method: A total of 201 Sri Lankan infants (128 male, 73 female) were prospectively assessed with the GMA before 44 weeks (writhing movements) and at 3 to 4 months (fidgeting movements), followed by the HINE at 5 to 6 months. Developmental outcomes were assessed using the Bayley Scales of Infant and Toddler Development, Fourth Edition and clinical assessment after 24 months.Results: The sensitivity of predicting cerebral palsy (CP) was lower with a single GMA assessment (writhing 89.5%, fidgeting 94.7%) or HINE (89.5%) compared to all three assessments combined (sensitivity 100%, 95% confidence interval [CI] = 82.4–100.0). The GMA and HINE were less predictive of non‐CP‐related developmental delays, particularly when single assessments were used (< 65% for all domains) compared to all three assessments combined (motor sensitivity > 86.9%, 95% CI = 66.4–97.2; cognitive sensitivity > 86.7%, 95% CI = 69.3–96.2; social–emotional sensitivity > 83.3%, 95% CI = 65.3–94.4). Specificity was lower for the prediction of CP‐related (40.1%) and non‐CP‐related developmental delays (< 46.0% for all).Interpretation: In an LMIC such as Sri Lanka, with limited access to specialist care and neuroimaging, combining two GMA measures and the HINE identified most infants with CP‐related and non‐CP‐related developmental delay, thereby allowing targeted early intervention therapies.
- 28 December 2024
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 67 (7) , 892-900
Open AccessPrediction of cerebral palsy and cognitive delay among high‐risk children in a developing nation: A successful early detection programme
Aim: To determine the feasibility of combining the Hammersmith Infant Neurological Examination (HINE) and General Movements Assessment (GMA) within a standard follow‐up schedule to predict developmental outcomes in infants at risk in low‐ and middle‐income countries (LMICs).Method: A total of 201 Sri Lankan infants (128 male, 73 female) were prospectively assessed with the GMA before 44 weeks (writhing movements) and at 3 to 4 months (fidgeting movements), followed by the HINE at 5 to 6 months. Developmental outcomes were assessed using the Bayley Scales of Infant and Toddler Development, Fourth Edition and clinical assessment after 24 months.Results: The sensitivity of predicting cerebral palsy (CP) was lower with a single GMA assessment (writhing 89.5%, fidgeting 94.7%) or HINE (89.5%) compared to all three assessments combined (sensitivity 100%, 95% confidence interval [CI] = 82.4–100.0). The GMA and HINE were less predictive of non‐CP‐related developmental delays, particularly when single assessments were used (< 65% for all domains) compared to all three assessments combined (motor sensitivity > 86.9%, 95% CI = 66.4–97.2; cognitive sensitivity > 86.7%, 95% CI = 69.3–96.2; social–emotional sensitivity > 83.3%, 95% CI = 65.3–94.4). Specificity was lower for the prediction of CP‐related (40.1%) and non‐CP‐related developmental delays (< 46.0% for all).Interpretation: In an LMIC such as Sri Lanka, with limited access to specialist care and neuroimaging, combining two GMA measures and the HINE identified most infants with CP‐related and non‐CP‐related developmental delay, thereby allowing targeted early intervention therapies.
- 7 March 2024
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 66 (9) , 1117-1118
Predicting cerebral palsy: The importance of evidence‐based screening programs appropriate for low‐ and middle‐income countries
This commentary is on the original articles by Romeo et al. and Tian et al. on pages 1173–1180 and 1181–1189 of this issue.
- 7 March 2024
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 66 (9) , 1117-1118
Predicting cerebral palsy: The importance of evidence‐based screening programs appropriate for low‐ and middle‐income countries
This commentary is on the original articles by Romeo et al. and Tian et al. on pages 1173–1180 and 1181–1189 of this issue.
- Open Access
- 5 March 2023
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 52 (1) , 33-38
Clinical profile and electroencephalogram characteristics of children with self-limited epilepsy with centro-temporal spikes attending paediatric neurology clinic, Teaching Hospital, Karapitiya, Sri Lanka
Introduction: Self-limited epilepsy with centro-temporal spikes (SLECTS) is the commonest type of epilepsy in childhood. Though considered a benign condition in the past, there is growing evidence of its multiple neuropsychiatric involvement. Antiepileptic drugs (AEDs) were not recommended in children with SLECTS due to its benign nature.Objectives: To describe the clinical profile and EEG characteristics of children with SLECTS followed up at the paediatric neurology unit, Teaching Hospital Karapitiya.Method: A descriptive cross-sectional study, using an interviewer-administered questionnaire, was carried out at the paediatric neurology clinic, THK from December 2021 to February 2022.Results:A total of 113 children with SLECTS was included in the study. Of them, 61.1% were males. Mean age of the sample was 10 ± 2.8 years. Mean age of onset of seizures was 7 ± 2.5 years. Majority (87.5%) were diagnosed after one seizure episode and 13.3% had a history of febrile seizures. Developmental delay was evident among 5 (4.4%) patients. Speech arrest (91.2%), hypersalivation (74.3%) and hemifacial sensory-motor seizures (56.6%) were the main manifestations; 87.6% had seizures at night. Abnormal EEGs were found in 110 (97.3%) patients and 51.3% had bilateral typical SLECTS changes in the EEG. Twenty-seven (23.9%) parents had concerns about their children's school performance. Behavioural problems were reported in 37 (32.7%). Child psychiatry referrals were done on 12 (10.2%) occasions. AEDs were used on 72.6% of patients and 27.4% had achieved remission. Sodium valproate was the most widely used AEDs (79.6%). Most of the patients were managed with monotherapy.Conclusions: There was male predominance. Mean age of onset of seizures was around 7 years; 87.5% were diagnosed after one seizure episode and 87.6% had seizures at night. The predominant EEG characteristic was bilateral typical centro-temporal spikes and waves. Speech arrest (91.2%), hypersalivation (74.3%) and hemifacial sensory-motor seizures (56.6%) were the main manifestations of the seizure.Sri Lanka Journal of Child Health, 2023; 52(1): 33-38
- 5 March 2023
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 52 (1) , 33-38
Open AccessClinical profile and electroencephalogram characteristics of children with self-limited epilepsy with centro-temporal spikes attending paediatric neurology clinic, Teaching Hospital, Karapitiya, Sri Lanka
Introduction: Self-limited epilepsy with centro-temporal spikes (SLECTS) is the commonest type of epilepsy in childhood. Though considered a benign condition in the past, there is growing evidence of its multiple neuropsychiatric involvement. Antiepileptic drugs (AEDs) were not recommended in children with SLECTS due to its benign nature.Objectives: To describe the clinical profile and EEG characteristics of children with SLECTS followed up at the paediatric neurology unit, Teaching Hospital Karapitiya.Method: A descriptive cross-sectional study, using an interviewer-administered questionnaire, was carried out at the paediatric neurology clinic, THK from December 2021 to February 2022.Results:A total of 113 children with SLECTS was included in the study. Of them, 61.1% were males. Mean age of the sample was 10 ± 2.8 years. Mean age of onset of seizures was 7 ± 2.5 years. Majority (87.5%) were diagnosed after one seizure episode and 13.3% had a history of febrile seizures. Developmental delay was evident among 5 (4.4%) patients. Speech arrest (91.2%), hypersalivation (74.3%) and hemifacial sensory-motor seizures (56.6%) were the main manifestations; 87.6% had seizures at night. Abnormal EEGs were found in 110 (97.3%) patients and 51.3% had bilateral typical SLECTS changes in the EEG. Twenty-seven (23.9%) parents had concerns about their children's school performance. Behavioural problems were reported in 37 (32.7%). Child psychiatry referrals were done on 12 (10.2%) occasions. AEDs were used on 72.6% of patients and 27.4% had achieved remission. Sodium valproate was the most widely used AEDs (79.6%). Most of the patients were managed with monotherapy.Conclusions: There was male predominance. Mean age of onset of seizures was around 7 years; 87.5% were diagnosed after one seizure episode and 87.6% had seizures at night. The predominant EEG characteristic was bilateral typical centro-temporal spikes and waves. Speech arrest (91.2%), hypersalivation (74.3%) and hemifacial sensory-motor seizures (56.6%) were the main manifestations of the seizure.Sri Lanka Journal of Child Health, 2023; 52(1): 33-38
- Open Access
- 5 March 2023
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 52 (1) , 104-107
A rare combination of a choroid plexus papilloma and Dandy-Walker variant
- 5 March 2023
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 52 (1) , 104-107
Open AccessA rare combination of a choroid plexus papilloma and Dandy-Walker variant
- Open Access
- 8 December 2022
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 13 (2) , 65
A case of cyanocobalamine responsive methylmalanoic acidemia presenting with metabolic stroke
- 8 December 2022
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 13 (2) , 65
Open AccessA case of cyanocobalamine responsive methylmalanoic acidemia presenting with metabolic stroke
- Open Access
- 5 June 2022
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 51 (2) , 301-302
A case of ketotic hypoglycaemia with cataract
- 5 June 2022
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 51 (2) , 301-302
Open AccessA case of ketotic hypoglycaemia with cataract
- Open Access
- 31 December 2021
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2021, 1-5
A Case of Carbamazepine-Induced Aggravation of Self-Limited Epilepsy with Centrotemporal Spikes Epilepsy and Valproate-Induced Hyperammonemic Encephalopathy in a Child with Heterozygous Gene Variant of Carbomoyl Phosphatase Synthetase Deficiency
Antiepileptics drugs are the mainstay of the management of epilepsy in children. Sodium valproate (VPA) and carbamazepine (CBZ) are widely used medications in childhood epilepsy. Hyperammonemia has been described as a known side effect of valproate therapy. It is known that VPA-associated HA is common among patients who hold genetic mutations of the carbomoyl phosphatase synthase 1 gene (CPS1). Aggravation of self-limited epilepsy with centrotemporal spikes (SLECTS) is a rare side effect of CBZ. Here, we present a child who had CBZ-induced aggravation of rolandic epilepsy and VPA-induced HA encephalopathy in the background of an unrecognised heterozygous gene variant of CPS1. An 8-year-old boy with SLECTS presented with a history of abnormal behaviours and drowsiness. He was apparently well until six years when he developed seizures in favour of rolandic epilepsy. His electroencephalogram (EEG) showed bilateral predominantly on the right-sided central-temporal spikes and waves. The diagnosis of SLECTS was made, and he was commenced on CBZ. Though he showed some improvement at the beginning, his seizure frequency increased when the dose of CBZ was increased. His repeat EEG showed electrical status in slow-wave sleep, and CBZ was stopped. Subsequently, he was started on VPA, and with that, he developed features of encephalopathy. He had elevated serum ammonia with normal liver functions. VPA was stopped with the suspicion of VPA-induced hyperammonemia. Tandem mass spectrometry did not show significant abnormality in the amino acid profile. Specific genetic analysis revealed a c.2756 C > T.p (Ser919Leu) heterozygote genetic mutation of the CSP 1 gene. This is a classic example where side effects of treatment determine the choice of antiepileptics drugs (AEDs) in childhood epilepsy. It is essential to keep in mind that SLECTS can be aggravated with certain AEDs, and VPA-induced HA in the absence of live failure could be due to underlying inherited metabolic disorders.
- 31 December 2021
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2021, 1-5
Open AccessA Case of Carbamazepine-Induced Aggravation of Self-Limited Epilepsy with Centrotemporal Spikes Epilepsy and Valproate-Induced Hyperammonemic Encephalopathy in a Child with Heterozygous Gene Variant of Carbomoyl Phosphatase Synthetase Deficiency
Antiepileptics drugs are the mainstay of the management of epilepsy in children. Sodium valproate (VPA) and carbamazepine (CBZ) are widely used medications in childhood epilepsy. Hyperammonemia has been described as a known side effect of valproate therapy. It is known that VPA-associated HA is common among patients who hold genetic mutations of the carbomoyl phosphatase synthase 1 gene (CPS1). Aggravation of self-limited epilepsy with centrotemporal spikes (SLECTS) is a rare side effect of CBZ. Here, we present a child who had CBZ-induced aggravation of rolandic epilepsy and VPA-induced HA encephalopathy in the background of an unrecognised heterozygous gene variant of CPS1. An 8-year-old boy with SLECTS presented with a history of abnormal behaviours and drowsiness. He was apparently well until six years when he developed seizures in favour of rolandic epilepsy. His electroencephalogram (EEG) showed bilateral predominantly on the right-sided central-temporal spikes and waves. The diagnosis of SLECTS was made, and he was commenced on CBZ. Though he showed some improvement at the beginning, his seizure frequency increased when the dose of CBZ was increased. His repeat EEG showed electrical status in slow-wave sleep, and CBZ was stopped. Subsequently, he was started on VPA, and with that, he developed features of encephalopathy. He had elevated serum ammonia with normal liver functions. VPA was stopped with the suspicion of VPA-induced hyperammonemia. Tandem mass spectrometry did not show significant abnormality in the amino acid profile. Specific genetic analysis revealed a c.2756 C > T.p (Ser919Leu) heterozygote genetic mutation of the CSP 1 gene. This is a classic example where side effects of treatment determine the choice of antiepileptics drugs (AEDs) in childhood epilepsy. It is essential to keep in mind that SLECTS can be aggravated with certain AEDs, and VPA-induced HA in the absence of live failure could be due to underlying inherited metabolic disorders.
- Open Access
- 17 December 2020
- Published by Sri Lanka Journals Online in Journal of the Ruhunu Clinical Society
- Vol. 25 (1) , 62-63
A case of Limb Girdle Muscular Dystrophy Type 4 C
- 17 December 2020
- Published by Sri Lanka Journals Online in Journal of the Ruhunu Clinical Society
- Vol. 25 (1) , 62-63
Open AccessA case of Limb Girdle Muscular Dystrophy Type 4 C
- Open Access
- 5 April 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 9 (1) , 52
A case of classical Galactosaemia presenting with Fanconi syndrome
- 5 April 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Diabetes Endocrinology and Metabolism
- Vol. 9 (1) , 52
Open AccessA case of classical Galactosaemia presenting with Fanconi syndrome